Australia's Imricor Medical rises on joint development deal
28/11/2023 04:45
** Shares of Imricor Medical Systems IMR.AX rise as much
as 3.5% to A$0.59
** The medical devices maker says it has signed a joint
development agreement with ADIS SA of Switzerland
** Co says it will use ADIS' AI modules in its Northstar 3D
mapping system, advancing its MRI scanning abilities
** Stock posts its biggest intraday pct fall since Nov 22
** More than 24,823 shares change hands, compared with the
30-day average volume of ~66,016 shares
** Imricor stock up 56.2% YTD, as of last close
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com;))
Recent news on Imricor Medical Systems
See all newsBrief: Imricor Medical Systems Says FDA Completes Review Of Imricor's Third PMA Module
Brief: Imricor Medical Systems Says FDA Accepts Imricor Pma Manufacturing Module
Brief: Imricor Medical Systems Says Anticipated FDA Clearances Of Additional Capital Equipment Expected To Broaden Product Offering Available To U.S. Customers
Imricor Medical Systems hits 3-month high on securing first US hospital customer
Brief: Imricor Medical Systems, Receives FDA 510(K) Clearance For Northstar Pediatric Label Expansion